)
Elanco Animal Health (ELAN) investor relations material
Elanco Animal Health Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 revenue reached $1,137 million, up 10% year-over-year and 9% organic constant currency, driven by innovation and strong growth in both pet health and farm animal segments.
Adjusted EBITDA grew 21% to $198 million, adjusted EPS rose to $0.19, and net leverage ratio improved to 3.7x, with further deleveraging targeted.
Major innovation products contributed $655 million year-to-date, prompting a raised full-year innovation revenue target to $840–$880 million.
Net loss for Q3 2025 was $34 million, mainly due to the absence of the prior year’s gain on the aqua business divestiture; adjusted net income was $94 million.
Full-year 2025 guidance was raised for revenue, adjusted EBITDA, and EPS, reflecting strong execution and innovation momentum.
Financial highlights
Q3 2025 revenue: $1,137 million (+10% YoY, +9% organic CC); adjusted EBITDA: $198 million (+21% YoY); adjusted EPS: $0.19 (+46% YoY); gross margin: 53.1%–53.4% (+90–120 bps YoY).
Adjusted net income: $94 million; reported net loss: $34 million.
Cash from operations: $219 million in Q3 2025, $452 million for nine months ended September 30, 2025.
Interest expense for Q3 2025: $34–$52 million, down year-over-year due to lower average debt balances.
Weighted-average shares outstanding: 496.8 million (basic and diluted) for Q3 2025.
Outlook and guidance
Full-year 2025 revenue guidance raised to $4,645–$4,670 million, with organic constant currency growth expected at 6–6.5%.
Adjusted EBITDA guidance increased to $880–$900 million; adjusted EPS guidance raised to $0.91–$0.94.
Q4 2025 revenue guidance: $1,085–$1,110 million; adjusted EBITDA: $168–$188 million; adjusted EPS: $0.09–$0.12.
Year-end net leverage ratio target improved to 3.7x–3.8x.
Management expects continued revenue growth driven by new product launches and international expansion.
Next Elanco Animal Health earnings date
Next Elanco Animal Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Animal Health Experts
Elanco Animal Health Inc. formerly a division of Eli Lilly, is an American company with multinational operations that specializes in animal health products and services. Elanco's portfolio includes a variety of products for both farm animals and pets, focusing on disease prevention, treatment, parasite control, and enhancing productivity in livestock. The company is headquartered in Greenfield, Indiana, and its shares are listed on the NYSE.
Foundation and Divestiture
Elanco was initially founded as a division of Eli Lilly in 1954. Initially, the division focused on feed additives to promote growth in livestock, later expanding to include a broader range of animal health products, such as vaccines and treatments for both livestock and pets. In 2019, Elanco was divested from Eli Lilly, becoming a standalone company. Today, Elanco is one of the largest animal health companies in the world, operating in the same sector as companies such as Zoetis and Virbac.
For Pets
Elanco produces products aimed at both companion animals and livestock. Its revenue is split nearly 50/50 between products for livestock and pets. Its product range for companion animals encompasses therapeutics, vaccines, parasiticides, and dermatology products. These offerings aim to address various health issues, such as flea and tick infestations, arthritis, and chronic pain, as well as supporting overall wellness. This is done both through medications, as well as through things such as anti-flea collars and similar products.
For Livestock
Elanco also plays a significant role in the livestock sector. The company offers a range of products and services aimed at improving the health, productivity, and well-being of farm animals such as cattle, poultry, and swine. Their portfolio for livestock includes vaccines, feed additives, antimicrobials, and products for parasite control and pain management. These products are designed to address health challenges and diseases common in livestock, enhance growth and efficiency, and ensure food safety.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)